1. Home
  2. CLDX vs NEOG Comparison

CLDX vs NEOG Comparison

Compare CLDX & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • NEOG
  • Stock Information
  • Founded
  • CLDX N/A
  • NEOG 1981
  • Country
  • CLDX United States
  • NEOG United States
  • Employees
  • CLDX N/A
  • NEOG N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CLDX Health Care
  • NEOG Health Care
  • Exchange
  • CLDX Nasdaq
  • NEOG Nasdaq
  • Market Cap
  • CLDX 1.6B
  • NEOG 1.3B
  • IPO Year
  • CLDX 2008
  • NEOG 1989
  • Fundamental
  • Price
  • CLDX $26.77
  • NEOG $5.88
  • Analyst Decision
  • CLDX Buy
  • NEOG Buy
  • Analyst Count
  • CLDX 9
  • NEOG 4
  • Target Price
  • CLDX $43.78
  • NEOG $8.83
  • AVG Volume (30 Days)
  • CLDX 958.4K
  • NEOG 6.9M
  • Earning Date
  • CLDX 11-05-2025
  • NEOG 10-09-2025
  • Dividend Yield
  • CLDX N/A
  • NEOG N/A
  • EPS Growth
  • CLDX N/A
  • NEOG N/A
  • EPS
  • CLDX N/A
  • NEOG N/A
  • Revenue
  • CLDX $5,790,000.00
  • NEOG $886,886,000.00
  • Revenue This Year
  • CLDX N/A
  • NEOG N/A
  • Revenue Next Year
  • CLDX N/A
  • NEOG $2.17
  • P/E Ratio
  • CLDX N/A
  • NEOG N/A
  • Revenue Growth
  • CLDX N/A
  • NEOG N/A
  • 52 Week Low
  • CLDX $14.40
  • NEOG $3.87
  • 52 Week High
  • CLDX $29.93
  • NEOG $16.79
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 56.87
  • NEOG 51.92
  • Support Level
  • CLDX $26.10
  • NEOG $5.77
  • Resistance Level
  • CLDX $27.87
  • NEOG $6.20
  • Average True Range (ATR)
  • CLDX 1.18
  • NEOG 0.36
  • MACD
  • CLDX -0.07
  • NEOG -0.01
  • Stochastic Oscillator
  • CLDX 67.91
  • NEOG 20.06

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Share on Social Networks: